State of Wisconsin Investment Board’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

State of Wisconsin Investment Board’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-19,300	Closed	-$445K	–	2122
2020 Q4	$445K	Sell	19,300 -2,400	-11%	-$30.4K	﹤0.01%	1569
2020 Q3	$221K	Hold	21,700	–	–	﹤0.01%	1899
2020 Q2	$323K	Hold	21,700	–	–	﹤0.01%	1540
2020 Q1	$265K	Buy	21,700 +10,400	+92%	+$165K	﹤0.01%	1529
2019 Q4	$179K	Hold	11,300	–	–	﹤0.01%	1589
2019 Q3	$139K	Buy	+11,300	New	+$128K	﹤0.01%	1524

State of Wisconsin Investment Board's PRVL Position: Q1 2021 in Review

State of Wisconsin Investment Board sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 19,300 shares — an estimated $445K sold.

State of Wisconsin Investment Board first reported a position in PRVL in Q3 2019 and held it in 6 quarters. The position peaked at $445K in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

State of Wisconsin Investment Board reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
State of Wisconsin Investment Board sold 19,300 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $445K.
State of Wisconsin Investment Board first reported a position in Prevail Therapeutics Inc. Common Stock in Q3 2019 and held it in 6 quarters.
State of Wisconsin Investment Board's Prevail Therapeutics Inc. Common Stock position peaked at $445K in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2021, filed 17 May 2021.